These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| o |
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| x |
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| o |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Date of event requiring this shell company report………………………………
For the transition period from ______ to ______
|
|
| Title of each class | Name of each exchange on which registered |
| Ordinary Shares, par value NIS 0.10 per share | Nasdaq Global Select Market |
|
U.S. GAAP
x
|
International Financial Reporting Standards as issued by the International Accounting Standards Board
o
|
Other
o
|
|
|
·
|
statements regarding projections of capital expenditures;
|
|
|
·
|
statements regarding competitive pressures;
|
|
|
·
|
statements regarding expected revenue growth;
|
|
|
·
|
statements regarding the expected growth demand for video caching and optimization;
|
|
|
·
|
statements regarding trends in mobile networks, including the development of a digital lifestyle, over-the-top applications, the need to manage mobile network traffic and cloud computing, among others;
|
|
|
·
|
statements regarding our ability to develop technologies to meet our customer demands and expand our product and service offerings;
|
|
|
·
|
statements regarding the acceptance and growth of our value-added services by our customers;
|
|
|
·
|
statements regarding the expected growth in the use of particular broadband applications;
|
|
|
·
|
statements as to our ability to meet anticipated cash needs based on our current business plan;
|
|
|
·
|
statements as to the impact of the rate of inflation and the political and security situation on our business;
|
|
|
·
|
statements regarding the price and market liquidity of our ordinary shares;
|
|
|
·
|
statements as to our ability to retain our current suppliers and subcontractors; and
|
|
|
·
|
statements regarding our future performance, sales, gross margins, expenses (including stock-based compensation expenses) and cost of revenues.
|
|
PART I
|
|
|
6
|
|
|
6
|
|
|
6
|
|
|
Selected Financial Data
|
6
|
|
Capitalization and Indebtedness
|
8
|
|
Reasons for Offer and Use of Proceeds
|
8
|
|
Risk Factors
|
8
|
|
22
|
|
|
History and Development of Allot
|
22
|
|
Business Overview
|
23
|
|
Organizational Structure
|
32
|
|
Property, Plants and Equipment
|
32
|
|
33
|
|
|
33
|
|
|
Operating Results
|
33
|
|
Liquidity and Capital Resources
|
45
|
|
Research and Development, Patents and Licenses
|
46
|
|
Trend Information
|
47
|
|
Off-Balance Sheet Arrangements
|
47
|
|
Contractual Obligations
|
47
|
|
48
|
|
|
Directors and Senior Management
|
48
|
|
Compensation of Officers and Directors
|
52
|
|
Board Practices
|
54
|
|
Employees
|
60
|
|
Share Ownership
|
61
|
|
64
|
|
|
Major Shareholders
|
64
|
|
Related Party Transactions
|
65
|
|
Interests of Experts and Counsel
|
66
|
|
66
|
|
Consolidated Financial Statements and Other Financial Information
|
66
|
|
Significant Changes
|
66
|
|
67
|
|
|
Stock Price History
|
67
|
|
Markets
|
67
|
|
68
|
|
|
Share Capital
|
68
|
|
Memorandum and Articles of Association
|
68
|
|
Material Contracts
|
73
|
|
Exchange Controls
|
73
|
|
Taxation
|
73
|
|
Documents on Display
|
87
|
|
Subsidiary Information
|
87
|
|
87
|
|
|
88
|
|
|
PART II
|
|
|
88
|
|
|
88
|
|
|
89
|
|
|
89
|
|
|
89
|
|
|
90
|
|
|
90
|
|
|
90
|
|
|
90
|
|
|
90
|
|
|
91
|
|
|
PART III
|
|
|
91
|
|
|
91
|
|
|
91
|
|
Year ended December 31,
|
||||||||||||||||||||
|
2009
|
2010
|
2011
|
2012
|
2013
|
||||||||||||||||
|
(in thousands of U.S. dollars, except per share and share data)
|
||||||||||||||||||||
|
Consolidated Statements of Operations:
|
||||||||||||||||||||
|
Revenues:
|
||||||||||||||||||||
|
Products
|
$ | 29,641 | $ | 40,852 | $ | 56,810 | $ | 77,127 | $ | 66,318 | ||||||||||
|
Services
|
12,110 | 16,120 | 20,943 | 27,625 | 30,227 | |||||||||||||||
|
Total revenues
|
41,751 | 56,972 | 77,753 | 104,752 | 96,545 | |||||||||||||||
|
Cost of revenues(2):
|
||||||||||||||||||||
|
Products
|
10,094 | 14,015 | 19,540 | 26,857 | 20,572 | |||||||||||||||
|
Services
|
1,741 | 1,970 | 2,635 | 4,180 | 6,246 | |||||||||||||||
|
Expenses related to the settlement of the Office of the Chief Scientist grants(1)
|
- | - | - | 15,886 | - | |||||||||||||||
|
Total cost of revenues
|
11,835 | 15,985 | 22,175 | 46,923 | 26,818 | |||||||||||||||
|
Gross profit
|
29,916 | 40,987 | 55,578 | 57,829 | 69,727 | |||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||
|
Research and development, gross
|
11,705 | 14,038 | 16,896 | 24,915 | 28,073 | |||||||||||||||
|
Less royalty-bearing grant participation
|
2,440 | 2,774 | 3,674 | 2,855 | 1,051 | |||||||||||||||
|
Research and development, net(2)
|
9,265 | 11,264 | 13,222 | 22,060 | 27,022 | |||||||||||||||
|
Sales and marketing(2)
|
20,408 | 22,021 | 26,543 | 34,127 | 39,817 | |||||||||||||||
|
General and administrative(2)
|
5,541 | 5,473 | 7,474 | 10,664 | 9,952 | |||||||||||||||
|
Total operating expenses
|
35,214 | 38,758 | 47,239 | 66,851 | 76,791 | |||||||||||||||
|
Operating income (loss)
|
(5,298 | ) | 2,229 | 8,339 | (9,022 | ) | (7,064 | ) | ||||||||||||
|
Financing income (expenses), net
|
(2,311 | ) | (7,907 | ) | 415 | 1,358 | 727 | |||||||||||||
|
Income (loss) before income tax expenses (benefit)
|
(7,609 | ) | (5,678 | ) | 8,754 | (7,664 | ) | (6,337 | ) | |||||||||||
|
Income tax expenses (benefit)
|
63 | 84 | (55 | ) | (926 | ) | 120 | |||||||||||||
|
Net income (loss)
|
$ | (7,672 | ) | $ | (5,762 | ) | $ | 8,809 | $ | (6,738 | ) | $ | (6,457 | ) | ||||||
|
Basic net earnings (loss) per share
|
$ | (0.35 | ) | $ | (0.25 | ) | $ | 0.35 | $ | (0.21 | ) | $ | (0.20 | ) | ||||||
|
Diluted net earnings (loss) per share
|
$ | (0.35 | ) | $ | (0.25 | ) | $ | 0.33 | $ | (0.21 | ) | $ | (0.20 | ) | ||||||
|
Weighted average number of shares used in computing basic net earnings (loss) per share
|
22,185,702 | 22,831,014 | 25,047,771 | 31,959,921 | 32,680,766 | |||||||||||||||
|
Weighted average number of shares used in computing diluted net earnings (loss) per share
|
22,185,702 | 22,831,014 | 27,071,872 | 31,959,921 | 32,680,766 | |||||||||||||||
|
|
(1)
|
Represents the full balance of the contingent liability related to grants received, which was paid in 2013.
|
|
|
(2)
|
Includes stock-based compensation expense related to options granted to employees and others as follows:
|
|
Year ended December 31,
|
||||||||||||||||||||
|
2009
|
2010
|
2011
|
2012
|
2013
|
||||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Cost of revenues
|
$ | 104 | $ | 95 | $ | 103 | $ | 222 | $ | 368 | ||||||||||
|
Research and development expenses, net
|
357 | 352 | 442 | 1,186 | 1,666 | |||||||||||||||
|
Sales and marketing expenses
|
775 | 851 | 1,001 | 2,060 | 3,106 | |||||||||||||||
|
General and administrative expenses
|
1,062 | 692 | 710 | 1,349 | 2,591 | |||||||||||||||
|
Total
|
$ | 2,298 | $ | 1,990 | $ | 2,256 | $ | 4,817 | $ | 7,731 | ||||||||||
|
At December 31,
|
||||||||||||||||||||
|
2009
|
2010
|
2011
|
2012
|
2013
|
||||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Consolidated balance sheet data:
|
||||||||||||||||||||
|
Cash and cash equivalents
|
$ | 36,470 | $ | 42,858 | $ | 116,682 | $ | 50,026 | $ | 42,813 | ||||||||||
|
Short-term deposits and restricted deposits
|
2,324 | 1,060 | 25,138 | 78,188 | 38,000 | |||||||||||||||
|
Marketable securities
|
14,490 | 15,531 | 17,580 | 14,841 | 40,798 | |||||||||||||||
|
Working capital
|
38,179 | 59,841 | 158,937 | 131,598 | 139,934 | |||||||||||||||
|
Total assets
|
82,943 | 95,187 | 197,058 | 221,791 | 199,257 | |||||||||||||||
|
Total liabilities
|
22,531 | 30,199 | 34,489 | 52,670 | 29,330 | |||||||||||||||
|
Accumulated deficit
|
(63,694 | ) | (69,456 | ) | (60,647 | ) | (67,385 | ) | (73,842 | ) | ||||||||||
|
Share capital
|
492 | 527 | 720 | 761 | 774 | |||||||||||||||
|
Total shareholders’ equity
|
60,412 | 64,988 | 162,569 | 169,121 | 169,927 | |||||||||||||||
|
·
|
substantial cash expenditures;
|
|
·
|
potentially dilutive issuances of equity securities;
|
|
·
|
the incurrence of debt and contingent liabilities;
|
|
·
|
a decrease in our profit margins; and
|
|
·
|
amortization of intangibles and potential impairment of goodwill.
|
|
·
|
current or future U.S. or foreign patents applications will be approved;
|
|
·
|
our issued patents will protect our intellectual property and not be held invalid or unenforceable if challenged by third
-
parties;
|
|
·
|
we will succeed in protecting our technology adequately in all key jurisdictions in which we or our competitors operate;
|
|
·
|
the patents of others will not have an adverse effect on our ability to do business; or
|
|
·
|
others will not independently develop similar or competing products or methods or design around any patents that may be issued to us.
|
|
·
|
announcements or introductions of technological innovations
,
new products, product enhancements or pricing policies by us or our competitors;
|
|
·
|
winning or losing contracts with service providers;
|
|
·
|
disputes or other developments with respect to our or our competitors’ intellectual property rights;
|
|
·
|
announcements of strategic partnerships, joint ventures or other agreements by us or our competitors;
|
|
·
|
recruitment or departure of key personnel;
|
|
·
|
regulatory developments in the markets in which we sell our products;
|
|
·
|
our sale of ordinary shares or other securities in the future;
|
|
·
|
changes in the estimation of the future size and growth of our markets; or
|
|
·
|
market conditions in our industry, the industries of our customers and the economy as a whole.
|
|
·
|
Analytics
solutions deliver accurate and meaningful network business intelligence to drive capacity planning, congestion management, service planning and marketing decisions.
|
|
·
|
Traffic Management
solutions prioritize existing network capacity, control congestion and optimize service delivery. Dynamic Quality of Service (QoS) enforcement enables effective traffic management strategies that minimize infrastructure and operating costs.
|
|
·
|
Video Caching and Optimization
solutions improve the quality and efficiency of OTT video delivery. New revenue opportunities are created through service packages designed especially for video consumers and revenue-sharing possibilities with content providers.
|
|
·
|
Policy Control and Charging
solutions drive personalized service plans and pay-for-use pricing models based on real-time consumption of bandwidth and OTT applications. We provide a single point of integration with provisioning and pricing systems.
|
|
·
|
Service Enablement
solutions facilitate a wide variety of cost-saving and revenue-generating use cases to create personalized customer experiences demanded by today’s sophisticated consumers.
|
|
·
|
Allot Service Gateway
integrates network intelligence, policy enforcement and revenue-generating services in a scalable, carrier-class platform designed for fixed, mobile (3G/4G/LTE) and converged broadband networks. The Allot Service Gateway accurately identifies subscriber traffic in real time at speeds up to 160 gigabits per second (Gbps), optimizes bandwidth utilization based on usage, enforces QoS policy, and steers traffic to digital lifestyle services deployed within or outside the platform. As the focal point for service enablement, The Allot Service Gateway allows service providers to reduce operating costs and drive new revenue by delivering the personalized service and quality of experience that the digital lifestyle demands.
|
|
·
|
Allot NetEnforcer
bandwidth management devices monitor and manage network traffic per application and per subscriber, enabling intelligent optimization of broadband and wide area network (WAN) services. With full duplex speeds ranging from 10 megabits per second (Mbps) to 8 Gbps, these devices provide essential visibility policy enforcement and traffic steering to added-value services in a wide range of service provider and enterprise networks.
|
|
·
|
Allot TierManager
: Provides and manages differentiated services and tiered service plans that are tailored to subscriber preferences.
|
|
·
|
Allot QuotaManager
: Provides and manages usage allowances and caps, with real-time metering of service consumption and dynamic enforcement of quota limits and overage policy.
|
|
·
|
Allot ChargeSmart
: Enables real-time, pay-for-use pricing, based on a user’s consumption of data and applications. It also integrates seamlessly in 3G and 4G mobile networks and implements the pricing model via standard telecommunication interfaces, such as Diameter Gx, Sd, Gy and Gz.
|
|
·
|
Allot ClearSee Analytics
: is a business intelligence application that helps network operators turn big data into
valuable insight for the decision-makers in their organization. Its self-service approach allows
network operators to synthesize and analyze large varieties and volumes of data with extreme
efficiency. Tools include built-in dashboards for mining Network, Application, Subscriber, Device,
and Quality of Experience data, plus Self-Service data mining for modeling fresh perspectives
and gaining deeper understanding of network usage and subscriber behavior.
|
|
·
|
Allot ClearSee Data Source
extracts a rich variety of raw traffic statistics from operator networks, enriches it with data from operator business systems, and loads it into a cutting-edge data warehouse where it is transformed into modeled data objects that are meaningful to telco operators and easy to manipulate using the Allot ClearSee Analytics application This valuable source data may also be exported to external analytics tools and other business applications.
|
|
·
|
Allot MediaSwift E
: Comprehensive caching and content delivery system for OTT video, P2P and other applications. Relieves network congestion caused by videos and improves quality of experience for users.
|
|
·
|
Allot VideoClass
: Optimizes OTT video content and delivery to ensure efficient utilization of mobile radio access network (RAN) resources and consistently high quality video to enhance viewer experience.
|
|
·
|
Allot WebSafe Personal
: Opt-in security services that allow ISP subscribers to define and enforce safe-browsing limits (Parental Control) and to prevent incoming malware from infecting their devices (Anti-Malware). Services are enforced at the network level, requiring no device involvement or battery consumption.
|
|
·
|
Allot WebSafe
: URL filtering service that blocks blacklisted content and enables access control to objectionable content on the Internet.
|
|
·
|
Allot ServiceProtector
: Attack detection and mitigation services that protect commercial networks against Denial of Service (DoS/DDoS) attacks, Zero Day attacks, worms, zombie and spambot behavior.
|
|
·
|
NetXplorer Analytics and Reporting
: Real-time reporting provides 30-second accuracy for timely troubleshooting and resolution of customer care issues, while historical traffic statistics facilitate analyses of usage trends and user behavior.
|
|
·
|
NetXplorer Data Collector
: Provides distributed data collection and storage at different points in the network in order to support growing and large-scale deployments with large volumes of network traffic.
|
|
·
|
NetAccounting Server
: Aggregates network-wide usage statistics and exports the data to external accounting systems in standard formats.
|
|
·
|
NetPolicy Provisioner
: Provides a virtual “bandwidth management device” for self-monitoring and self-provisioning by a networks operator’s VPN, ISP and managed services customers
|
|
·
|
unlimited 24/7 access to Allot’s support organization, via phone, emails and online support system;
|
|
·
|
expedited replacement units in the event of a warranty claim;
|
|
·
|
software updates and upgrades offering new features and addressing new and changing network applications; and
|
|
·
|
periodic updates of solution documentation and technical information.
|
|
Company
|
Jurisdiction of Incorporation
|
Percentage Ownership
|
||
|
Allot Communications Inc.
|
United States
|
100%
|
||
|
Allot Communications Europe SARL
|
France
|
100%
|
||
|
Allot Communications (Asia Pacific) Pte. Limited
|
Singapore
|
100%
|
||
|
Allot Communications (UK) Limited
|
United Kingdom
|
100%
|
||
|
Allot Communications Japan K.K.
|
Japan
|
100%
|
||
|
Allot Communications (New Zealand) Limited
|
New Zealand
|
100%
|
||
|
Oversi Networks Ltd.
|
Israel
|
100%
|
||
|
Allot Communications (Hong Kong) Ltd
|
Hong Kong
|
100%
|
||
|
Allot Communications Africa (PTY) Ltd
|
South Africa
|
100%
|
||
|
Allot Communications India Private Ltd
|
India
|
100%
|
|
|
Year Ended December 31,
|
|||||||||||
|
2011
|
2012
|
2013
|
||||||||||
|
United States
|
12 | % | 24 | % | 22 | % | ||||||
|
Europe
|
50 | 38 | 23 | |||||||||
|
Asia and Oceania
|
26 | 21 | 31 | |||||||||
|
Middle East and Africa
|
3 | 10 | 19 | |||||||||
|
Americas (excluding United States)
|
9 | 7 | 5 | |||||||||
|
Total
|
100 | % | 100 | % | 100 | % | ||||||
|
·
|
Provision for returns;
|
|
·
|
Warranty costs;
|
|
·
|
Allowance for doubtful accounts;
|
|
·
|
Accounting for stock-based compensation;
|
|
·
|
Marketable securities;
|
|
·
|
Impairment of goodwill and long lived assets;
|
|
·
|
Income taxes; and
|
|
Year Ended December 31,
|
||||||||||||
|
2011
|
2012
|
2013
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
73.1 | % | 73.6 | % | 68.7 | % | ||||||
|
Services
|
26.9 | 26.4 | 31.3 | |||||||||
|
Total revenues
|
100.0 | 100.0 | 100.0 | |||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
25.1 | 25.6 | 21.3 | |||||||||
|
Services
|
3.4 | 4.0 | 6.5 | |||||||||
|
Total cost of revenues
|
28.5 | 44.8 | 27.8 | |||||||||
|
Gross profit
|
71.5 | 55.2 | 72.2 | |||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development, net
|
17.1 | 21.1 | 28.0 | |||||||||
|
Sales and marketing
|
34.1 | 32.5 | 41.2 | |||||||||
|
General and administrative
|
9.6 | 10.2 | 10.3 | |||||||||
|
Total operating expenses
|
60.8 | 63.8 | 79.5 | |||||||||
|
Operating profit (loss)
|
10.7 | (8.6 | ) | (7.3 | ) | |||||||
|
Financing income (expenses), net
|
0.5 | (1.3 | ) | 0.8 | ||||||||
|
Profit (loss) before income tax expense (benefit)
|
11.2 | (7.3 | ) | (6.6 | ) | |||||||
|
Income tax (expense) benefit
|
0.1 | 0.9 | (0.1 | ) | ||||||||
|
Net profit (loss)
|
11.3 | % | (6.4 | )% | (6.7 | )% | ||||||
|
Payments due by period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than 1 year
|
1– 3 years
|
3-5 years
|
Over 5 years
|
|||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Operating leases — offices(1)
|
$ | 8,742 | $ | 2,447 | $ | 5,389 | $ | 906 | $ | - | ||||||||||
|
Operating leases — vehicles
|
799 | 461 | 338 | - | - | |||||||||||||||
|
Purchase obligations
|
1,166 | 934 | 116 | 116 | - | |||||||||||||||
|
Accrued severance pay(2)
|
282 | - | - | - | 282 | |||||||||||||||
|
Total
|
$ | 10,989 | $ | 3,842 | $ | 5,843 | $ | 1,022 | $ | 282 | ||||||||||
|
(1)
|
Consists primarily of an operating lease for our facilities in Hod Hasharon, Israel, as well as operating leases for facilities leased by our subsidiaries.
|
|
(2)
|
Severance pay relates to accrued severance obligations to our Israeli employees as required under Israeli labor law. These obligations are payable only upon termination, retirement or death of the respective employee and there is no obligation if the employee voluntarily resigns. Of this amount, $28,000 is unfunded.
|
|
Name
|
Age
|
Position
|
|
Directors
|
||
|
Shraga Katz
|
61
|
Chairman of the Board
|
|
Rami Hadar
|
50
|
Director, Chief Executive Officer and President
|
|
Itzhak Danziger
|
65
|
Director
|
|
Nurit Benjamini(1)(2)(3)
|
47
|
Director
|
|
Steven D. Levy(1)(2)
|
57
|
Director
|
|
Dov Baharav(1)(2)
|
63
|
Director
|
|
Yigal Jacoby
|
53
|
Director
|
|
Executive Officers
|
||
|
Nachum Falek
|
42
|
Chief Financial Officer
|
|
Amir Hochbaum
|
54
|
Vice President — Research and Development
|
|
Anat Shenig
|
44
|
Vice President — Human Resources
|
|
Andrei Elefant
|
40
|
Vice President — Product Management and Marketing
|
|
Gary Drutin
|
52
|
Vice President — International Sales
|
|
Itamar Rosen
|
49
|
Vice President — Legal Affairs, General Counsel and Company Secretary
|
|
Jay Klein
|
50
|
Vice President — Chief Technology Officer
|
|
Lior Moyal
|
42
|
Vice President — Business Development
|
|
Pini Gvili
|
48
|
Vice President — Operations
|
|
Ramy Moriah
|
58
|
Vice President — Customer Care and Information Technology
|
|
Vin Costello
|
57
|
Vice President and General Manager — The Americas
|
|
●
|
Objectives:
To attract, motivate and retain highly experienced personnel who will provide leadership for Allot’s success and enhance shareholder value, and to provide for each executive officer an opportunity to advance in a growing organization.
|
|
●
|
Compensation instruments:
Includes base salary; limited personal benefits and perquisites; cash bonuses; equity-based awards; and retirement and termination arrangements.
|
|
●
|
Ratio between fixed and variable compensation:
Allot aims to balance the mix of fixed compensation (such as base salary) and variable compensation (such as performance based cash bonuses and equity-based awards) pursuant to the ranges set forth in the Compensation Policy in order, among other things, to tie the compensation of each executive officer to Allot’s financial and strategic achievements and enhance the alignment between the executive officer’s interests and the long-term interests of Allot and its shareholders.
|
|
●
|
Internal compensation ratio:
Allot will target a ratio between overall compensation of the executive officers and the average and median salary of the other employees of Allot, as set forth in the Compensation Policy, to ensure that levels of executive compensation will not have a negative impact on work relations in Allot.
|
|
●
|
Base salary, benefits and perquisites:
The Compensation Policy provides guidelines and criteria for determining base salary, benefits and perquisites for executive officers.
|
|
●
|
Cash bonuses:
Allot’s policy is to allow annual cash bonuses, which may be awarded to executive officers pursuant to the guidelines and criteria, including caps on maximum payouts, set forth in the Compensation Policy.
|
|
●
|
“Clawback”:
In the event of an accounting restatement, Allot shall be entitled to recover from current executive officers bonus compensation in the amount of the excess over what would have been paid under the accounting restatement, with a three-year look-back.
|
|
●
|
Equity-based awards:
Allot’s policy is to provide equity-based awards in the form of stock options, restricted stock units and other forms of equity, which may be awarded to executive officers pursuant to the guidelines and criteria, including minimum vesting period, set forth in the Compensation Policy.
|
|
●
|
Retirement and termination:
The Compensation Policy provides guidelines and criteria for determining retirement and termination arrangements of executive officers, including limitations thereon.
|
|
●
|
Exculpation, indemnification and insurance:
The Compensation Policy provides guidelines and criteria for providing directors and executive officers with exculpation, indemnification and insurance.
|
|
●
|
Directors:
The Compensation Policy provides guidelines for the compensation of our directors in accordance with applicable regulations promulgated under the Companies Law, and for equity-based awards that may be granted to directors pursuant to the guidelines and criteria, including minimum vesting period, set forth in the Compensation Policy.
|
|
●
|
Applicability:
The Compensation Policy applies to all compensation agreements and arrangements approved after the date on which the Compensation Policy is approved by the shareholders.
|
|
●
|
Review:
The compensation and nominating committee and the Board of Directors of Allot reviews the adequacy of the Compensation Policy from time to time, as required by the Companies Law.
|
|
|
·
|
the majority of shares voted at the meeting, including at least a majority of the shares of non-controlling shareholder(s) and shareholders who do not have a personal interest in the election of the outside director (other than a personal interest that does not result from the shareholder's relationship with a controlling shareholder), voted at the meeting, excluding abstentions, vote in favor of the election of the outside director; or
|
|
|
·
|
the total number of shares of non-controlling shareholders and shareholders who do not have a personal interest in the election of the outside director (excluding a personal interest that does not result from the shareholder's relationship with a controlling shareholder) voted against the election of the outside director does not exceed two percent of the aggregate voting rights in the company.
|
|
|
·
|
the chairperson of the board of directors;
|
|
|
·
|
a controlling shareholder or a relative of a controlling shareholder (as defined in the Companies Law); or
|
|
|
·
|
any director who is engaged by, or provides services on a regular basis to the company, the company’s controlling shareholder or an entity controlled by a controlling shareholder or any director who generally relies on a controlling shareholder for his or her livelihood.
|
|
|
·
|
retaining and terminating the company’s independent auditors, subject to shareholder ratification;
|
|
|
·
|
pre-approval of audit and non-audit services provided by the independent auditors; and
|
|
|
·
|
approval of transactions with office holders and controlling shareholders, as described above, and other related-party transactions.
|
|
|
·
|
approving, and recommending to the board of directors and the shareholders for their approval, the compensation of our Chief Executive Officer and other executive officers;
|
|
|
·
|
granting options to our employees and the employees of our subsidiaries;
|
|
|
·
|
recommending candidates for nomination as members of our board of directors; and
|
|
|
·
|
developing and recommending to the board corporate governance guidelines and a code of business ethics and conduct in accordance with applicable laws.
|
|
|
·
|
a breach of duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
|
|
·
|
a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
|
|
|
·
|
an act or omission committed with intent to derive illegal personal benefit; or
|
|
|
·
|
a fine, civil fine, monetary sanction or forfeit levied against the office holder.
|
|
December 31,
|
||||||||||||
|
Department
|
2011
|
2012
|
2013
|
|||||||||
|
Manufacturing and operations
|
19 | 18 | 16 | |||||||||
|
Research and development
|
117 | 178 | 172 | |||||||||
|
Sales, marketing, service and support
|
153 | 199 | 199 | |||||||||
|
Management and administration
|
35 | 47 | 44 | |||||||||
|
Total
|
324 | 442 | 430 | |||||||||
|
Name of Beneficial Owner
|
Number of Shares Beneficially Held(1)
|
Percent of Class
|
||||||
|
Directors
|
||||||||
|
Itzhak Danziger
|
* | * | ||||||
|
Nurit Benjamini
|
* | * | ||||||
|
Rami Hadar
|
* | * | ||||||
|
Shraga Katz
|
* | * | ||||||
|
Steven D. Levy
|
* | * | ||||||
|
Yigal Jacoby
|
* | * | ||||||
|
Dov Baharav
|
* | * | ||||||
|
Executive Officers
|
||||||||
|
Amir Hochbaum
|
* | * | ||||||
|
Anat Shenig
|
* | * | ||||||
|
Andrei Elefant
|
* | * | ||||||
|
Gary Drutin
|
* | * | ||||||
|
Itamar Rosen
|
* | * | ||||||
|
Jay Klein
|
* | * | ||||||
|
Lior Moyal
|
* | * | ||||||
|
Nachum Falek
|
* | * | ||||||
|
Pini Gvili
|
* | * | ||||||
|
Ramy Moriah
|
* | * | ||||||
|
Vin Costello
|
* | * | ||||||
|
All directors and executive officers as a group (18 persons)
|
635,242 | 1.89 | % | |||||
|
*
|
Less than one percent of the outstanding ordinary shares.
|
|
(1)
|
As used in this table, “beneficial ownership” is determined in accordance with the rules of the SEC and consists of either or both voting or investment power with respect to securities. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from March 6, 2014 through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for the purpose of computing the ownership percentage of any other person. Except as otherwise indicated, the persons named in the table have reported that they have sole voting and sole investment power with respect to all shares of common stock shown as beneficially owned by them. The amounts and percentages are based upon 33,001,100 ordinary shares outstanding as of March 6, 2014
pursuant to Rule 13d-3(d)(1)(i) under the Exchange Act.
|
|
Ordinary Shares
Beneficially
Owned(1)
|
Percentage of
Ordinary Shares
Beneficially
Owned
|
|||||||
|
FMR LLC (2)
|
3,250,691 | 9.9 | % | |||||
|
Zohar Zisapel (3)
|
2,842,378 | 8.6 | % | |||||
|
T. Rowe Price Associates, Inc (4)
|
2,786,740 | 8.4 | % | |||||
|
Migdal Insurance & Financial holdings Ltd (5)
|
2,616,542 | 7.9 | % | |||||
|
Psagot Investment Ltd (6)
|
1,876,791 | 5.7 | % | |||||
|
|
(1)
|
As used in this table, “beneficial ownership” means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from March 6, 2014 through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based upon 33,001,100 ordinary shares outstanding as of March 6, 2014.
|
|
|
(2)
|
Based on a Schedule 13G/A filed on February 14, 2013. Includes 2,920,191 shares beneficially owned by Fidelity Management & Research Company, a wholly-owned subsidiary of FMR LLC, of which Edward C. Johnson 3d and FMR LLC, through its control of Fidelity Management & Research Company, and the funds each has sole dispositive power; Edward C. Johnson 3d and FMR LLC, through its control of Pyramis Global Advisors, LLC , each has sole dispositive power and sole voting power over 11,900 shares; and Edward C. Johnson 3d and FMR LLC, through its control of Pyramis Global Advisors Trust Company each has sole dispositive power and sole voting power over 318,600 shares. The address of the FMR entities is 82 Devonshire St., Boston MA 02109.
|
|
|
(3)
|
Based on a Schedule 13G/A filed on January 13, 2011. Consists of 2,777,487 shares held by Zohar Zisapel and 64,891 shares held by Lomsha Ltd., an Israeli company controlled by Zohar Zisapel. The address of Mr. Zisapel and Lomsha Ltd. is 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel.
|
|
|
(4)
|
Based on a Schedule 13G/A filed on February 13, 2014. Of these shares, T. Rowe Price Associate reported that it held sole voting power over 613,300 and sole dispositive power over 2,786,740 shares. The address of T. Rowe Price Associates Inc is 100 E. Prat Street, Baltimore, Maryland 21202.
|
|
|
(5)
|
Based on a Schedule 13G/A filed on February 13, 2014.Midgal Insurance & Financial Holdings Ltd reported that it held shared voting power and shared dispositive power over these shares. Of these shares, 2,553,131 shares are held for members of the public through, among others, provident funds, mutual funds, pension funds and insurance policies, which are managed by subsidiaries of Midgal Insurance & Financial Holdings Ltd, according to the following segmentation: 1,465,149 shares are held by Profit participating life assurance accounts; 991,940 shares are held by Provident funds and companies that manage provident funds and 96,042 shares are held by companies for the management of funds for joint investments in trusteeship, each of which subsidiaries operates under independent management and makes independent voting and investment decisions. The address of the reporting person is 4 Efal Street; P.O BOX 3063; Petach Tikva 49512, Israel.
|
|
|
(6)
|
Based on a Schedule 13G filed on February 19, 2014. Psagot Investment House Ltd. reported that it held shared voting power and shared dispositive power over these shares. Consists of 699,295 shares beneficially owned by Psagot Securities Ltd; 327,646 shares beneficially owned by Psagot Provident Funds and Pension Ltd; 34,194 shares beneficially owned by Psagot Mutual Funds Ltd (of this amount, 8,508 shares may also be considered beneficially owned by Psagot Securities Ltd., but are not included in the shares beneficially owned by Psagot Securities Ltd., as indicated above); and 815,656 shares beneficially owned by Psagot Exchange Traded Notes Ltd. The address of the Psagot entities is Psagot Investment House Ltd. – 14 Ahad Ha’am Street, Tel Aviv 65142, Israel.
|
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
Year
|
High
|
Low
|
High
|
Low
|
||||||||||||
| 2010 | $ | 11.64 | $ | 4.00 | NIS |
42.57
|
NIS |
37.20
|
||||||||
|
2011
|
19.05 | 9.45 | 71.22 | 35.74 | ||||||||||||
|
2012
|
28.03 | 15.55 | 111.60 | 58.56 | ||||||||||||
|
2013
|
18.28 | 11.01 | 68.12 | 39.2 | ||||||||||||
|
2014 (through March 6, 2014)
|
17.06 | 14.93 | 62.96 | 52.01 | ||||||||||||
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
2012
|
High
|
Low
|
High
|
Low
|
||||||||||||
|
First Quarter
|
$ | 23.25 | $ | 15.55 | NIS | 86.17 | NIS |
58.56
|
||||||||
|
Second Quarter
|
28.03 | 21.87 | 110.00 | 83.07 | ||||||||||||
|
Third Quarter
|
27.82 | 21.32 | 111.60 | 88.58 | ||||||||||||
|
Fourth Quarter
|
25.50 | 17.12 | 99.72 | 63.60 | ||||||||||||
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
2013
|
High
|
Low
|
High
|
Low
|
||||||||||||
| First Quarter | $ | 18.28 | $ | 11.94 | NIS |
68.12
|
NIS | 45.19 | ||||||||
|
Second Quarter
|
13.79 | 11.01 | 50.14 | 39.20 | ||||||||||||
|
Third Quarter
|
15.55 | 12.02 | 54.86 | 42.86 | ||||||||||||
|
Fourth Quarter
|
15.13 | 12.63 | 53.18 | 45.04 | ||||||||||||
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
Most Recent Six Months
|
High
|
Low
|
High
|
Low
|
||||||||||||
| March 2014 (through March 6, 2014) | $ | 16.51 | $ | 16.29 | NIS | 58.22 | NIS |
57.13
|
||||||||
|
February 2014
|
17.13 | 15.78 | 60.28 | 54.54 | ||||||||||||
|
January 2014
|
17.06 | 14.93 | 62.96 | 52.01 | ||||||||||||
|
December 2013
|
15.13 | 13.02 | 53.18 | 45.89 | ||||||||||||
|
November 2013
|
13.77 | 12.71 | 48.17 | 45.08 | ||||||||||||
|
October 2013
|
14.35 | 12.63 | 50.43 | 45.04 | ||||||||||||
|
Material Contract
|
Location
|
|
|
Agreement with Flextronics (Israel) Ltd.
|
“ITEM 4.B: Information on the Company–Business Overview–Manufacturing.”
|
|
|
·
|
The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;
|
|
|
·
|
The research and development must be for the promotion of the company; and
|
|
|
·
|
The research and development is carried out by or on behalf of the company seeking such tax deduction.
|
|
|
·
|
Amortization of the cost of purchased know-how and patents and of rights to use a patent and know-how which are used for the development or advancement of the company, over an eight-year period;
|
|
|
·
|
Under specified conditions, an election to file consolidated tax returns with additional related Israeli Industrial Companies; and
|
|
|
·
|
Expenses related to a public offering in Israel and in recognized stock markets outside Israel, are deductible in equal amounts over three years.
|
|
|
·
|
Extension of the benefit period to up to ten years.
|
|
|
·
|
An additional period of reduced corporate tax liability at rates ranging between 10% and 25%, depending on the level of foreign (that is, non-Israeli) ownership of our shares. Those tax rates and the related levels of foreign investment are as set forth in the following table:
|
|
Rate of Reduced Tax
|
Reduced Tax Period
|
Tax Exemption Period
|
Percent of Foreign Ownership
|
|||
|
25
|
0 years
|
10 years
|
0-25%
|
|||
|
25
|
0 years
|
10 years
|
25-48.99%
|
|||
|
20
|
0 years
|
10 years
|
49-73.99%
|
|||
|
15
|
0 years
|
10 years
|
74-89.99%
|
|||
|
10
|
0 years
|
10 years
|
90-100%
|
|
Rate of Reduced Tax
|
Reduced Tax Period
|
Tax Exemption Period
|
Percent of Foreign Ownership
|
|||
|
25
|
1 years
|
6 years
|
0-25%
|
|||
|
25
|
4 years
|
6 years
|
25-48.99%
|
|||
|
20
|
4 years
|
6 years
|
49-73.99%
|
|||
|
15
|
4 years
|
6 years
|
74-89.99%
|
|||
|
10
|
4 years
|
6 years
|
90-100%
|
|
Rate of Reduced Tax
|
Reduced Tax Period
|
Tax Exemption Period
|
Percent of Foreign Ownership
|
|||
|
25
|
5 years
|
2 years
|
0-25%
|
|||
|
25
|
8 years
|
2 years
|
25-48.99%
|
|||
|
20
|
8 years
|
2 years
|
49-73.99%
|
|||
|
15
|
8 years
|
2 years
|
74-89.99%
|
|||
|
10
|
8 years
|
2 years
|
90-100%
|
|
·
|
Similar to the currently available alternative route, exemption from corporate tax on undistributed income for a period of two to ten years, depending on the geographic location of the Benefited Enterprise within Israel, and a reduced corporate tax rate of 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in each year. Benefits may be granted for a term of seven to ten years, depending on the level of foreign investment in the company. If the company pays a dividend out of income derived from the Benefited Enterprise during the tax exemption period, such income will be subject to corporate tax at the applicable rate (10%-25%) in respect of the gross amount of the dividend that we may be distributed. The company is required to withhold tax at the source at a rate of 15% from any dividends distributed from income derived from the Benefited Enterprise; and
|
|
·
|
A special tax route, which enables companies owning facilities in certain geographical locations in Israel to pay corporate tax at the rate of 11.5% on income of the Benefited Enterprise. The benefits period is ten years. Upon payment of dividends, the company is required to withhold tax at source at a rate of 15% for Israeli residents and at a rate of 4% for foreign residents.
|
|
|
·
|
financial institutions or insurance companies;
|
|
|
·
|
real estate investment trusts, regulated investment companies or grantor trusts;
|
|
|
·
|
dealers or traders in securities or currencies;
|
|
|
·
|
tax-exempt entities;
|
|
|
·
|
certain former citizens or long-term residents of the United States;
|
|
|
·
|
persons that will hold our shares through a partnership or other pass-through entity;
|
|
|
·
|
persons that received our shares as compensation for the performance of services;
|
|
|
·
|
persons that will hold our shares as part of a “hedging” or “conversion” transaction or as a position in a “straddle” for United States federal income tax purposes;
|
|
|
·
|
persons whose “functional currency” is not the United States dollar; or
|
|
|
·
|
holders that own directly, indirectly or through attribution 10.0% or more of the voting power or value of our shares.
|
|
|
·
|
a citizen or resident of the United States;
|
|
|
·
|
corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state thereof, including the District of Columbia;
|
|
|
·
|
an estate the income of which is subject to United States federal income taxation regardless of its source; or
|
|
|
·
|
a trust if such trust has validly elected to be treated as a United States person for United States federal income tax purposes or if (1) a court within the United States is able to exercise primary supervision over its administration and (2) one or more United States persons have the authority to control all of the substantial decisions of such trust.
|
|
|
·
|
such gain is effectively connected with your conduct of a trade or business in the United States; or
|
|
|
·
|
you are an individual and have been present in the United States for 183 days or more in the taxable year of such sale or exchange and certain other conditions are met.
|
|
|
·
|
at least 50 percent of the average value of its gross assets (based on the quarterly value of such gross assets) is attributable to assets that produce “passive income” or are held for the production of passive income.
|
|
·
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
|
·
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
|
|
·
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
|
Year ended December, 31,
|
||||||||
|
2012
|
2013
|
|||||||
|
(in thousands of U.S. dollars)
|
||||||||
|
Audit Fees(1)
|
$ | 285 | $ | 275 | ||||
|
Audit-Related Fees(2)
|
105 | 25 | ||||||
|
Tax Fees(3)
|
73 | 83 | ||||||
|
All Other Fees(4)
|
41 | 15 | ||||||
|
Total
|
$ | 504 | $ | 398 | ||||
|
(1)
|
“Audit fees” include fees for services performed by our independent public accounting firm in connection with our annual audit for 2012 and 2013, certain procedures regarding our quarterly financial results submitted on Form 6-K, the filing of our Form F-3, fees related to public offering, and consultation concerning financial accounting and reporting standards.
|
|
(2)
|
“Audit-Related fees” relate to assurance and associated services that are traditionally performed by the independent auditor, including: accounting consultation and consultation concerning financial accounting, reporting standards and due diligence investigations
.
|
|
(3)
|
“Tax fees” include fees for professional services rendered by our independent registered public accounting firm for tax compliance, transfer pricing and tax advice on actual or contemplated transactions.
|
|
(4)
|
“Other fees” include fees for services rendered by our independent registered public accounting firm with respect to government incentives and other matters.
|
|
|
·
|
We follow the requirements of Israeli law with respect to the quorum requirement for meetings of our shareholders, which are different from the requirements of Rule 5620(c). Under our articles of association, the quorum required for an ordinary meeting of shareholders consists of at least two shareholders present in person, by proxy or by written ballot, who hold or represent between them at least 25% of the voting power of our shares, instead of 33 1/3% of the issued share capital provided by under the NASDAQ Global Market requirements. This quorum requirement is based on the default requirement set forth in the Companies Law. We submitted a letter from our outside counsel in connection with this item prior to our initial public offering in November 2006.
|
|
|
·
|
We do not seek shareholder approval for equity compensation plans in accordance with the requirements of the Companies Law, which does not fully reflect the requirements of Rule 5635(c). Under Israeli law, we may amend our 2006 Incentive Compensation Plan by the approval of our board of directors, and without shareholder approval as is generally required under Rule 5635(c). Under Israeli law, the adoption and amendment of equity compensation plans, including changes to the reserved shares, do not require shareholder approval. We submitted a letter from our outside counsel in connection with this item in June 2008.
|
|
Allot Communications Ltd.
|
|||
|
|
By:
|
/s/ Rami Hadar | |
| Rami Hadar | |||
|
Chief Executive Officer and President
|
|||
|
Number
|
Description
|
|
|
1.1
|
Articles of Association of the Registrant
|
|
|
1.2
|
Certificate of Name Change
(1)
|
|
|
2.1
|
Specimen share certificate
(1)
|
|
|
4.1
|
Non-Stabilized Lease Agreement, dated February 13, 2006, by and among, Aderet Hod Hasharon Ltd., Miritz, Inc., Leah and Israel Ruben Assets Ltd., Tamar and Moshe Cohen Assets Ltd., Drish Assets Ltd., S. L. A. A. Assets and Consulting Ltd., Iris Katz Ltd., Y. A. Groder Investments Ltd., Ginotel Hod Hasharon 2000 Ltd. and Allot Communications Ltd.
(1)
|
|
|
4.2
|
Key Employees of Subsidiaries and Consultants Share Incentive Plan (1997)
(1)
|
|
|
4.3
|
Key Employees Share Incentive Plan (1997)
(1)
|
|
|
4.4
|
Key Employees Share Incentive Plan (2003)
(1)
|
|
|
4.5
|
2006 Incentive Compensation Plan
(2)
|
|
|
4.6
|
Manufacturing Agreement, dated July 19, 2007, by and between Flextronics (Israel) Ltd. and the Registrant*
(3)
|
|
|
4.7
|
Amendment No. 1, dated September 1, 2012, to the Manufacturing Agreement, dated July 19, 2007, by and between Flextronics (Israel) Ltd. and the Registrant*
(4)
|
|
|
8.1
|
List of Subsidiaries of the Registrant
|
|
|
11.1
|
Code of Ethics
(5)
|
|
|
12.1
|
Certification of Principal Executive Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
|
|
|
12.2
|
Certification of Principal Financial Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
|
|
|
13.1
|
Certification of Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) and Rule 15d-14(b) (Section 906 Certifications)
(6)
|
|
|
14.1
|
Consent of Kost Forer Gabbay & Kasierer
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase Document
|
|
|
101.CAL
|
XBRL Taxonomy Calculation Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Label Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
(1)
|
Previously filed with the Securities and Exchange Commission on October 31, 2006 pursuant to a registration statement on Form F-1 (File No. 333-138313) and incorporated by reference herein.
|
|
|
(2)
|
Previously filed with the Securities and Exchange Commission on March 21, 2013 as Exhibit 4.5 to Form 20-F for the year ended December 31, 2012 and incorporated by reference herein.
|
|
|
(3)
|
Previously filed with the Securities and Exchange Commission on June 27, 2008 as Exhibit 4.11 to Form 20-F for the year ended December 31, 2007 and incorporated by reference herein.
|
|
|
(4)
|
Previously filed with the Securities and Exchange Commission on March 21, 2013 as Exhibit 4.7 to Form 20-F for the year ended December 31, 2012 and incorporated by reference herein.
|
|
|
(5)
|
Previously filed with the Securities and Exchange Commission on June 28, 2007 as Exhibit 4 to Form 20-F for the year ended December 31, 2006 and incorporated by reference herein.
|
|
|
(6)
|
Furnished herewith.
|
|
|
*
|
Portions of this exhibit were omitted and have been filed separately with the Secretary of the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act.
|
|
Page
|
|
|
F - 3 - F - 5
|
|
|
F - 6 - F - 7
|
|
|
F - 8
|
|
|
F - 9 - F - 10
|
|
|
F - 11 - F - 12
|
|
|
F - 13 - F - 47
|
|
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 6706703, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
|
Tel Aviv, Israel
March 26, 2014
|
/s/
Kost Forer Gabbay & Kasierer
KOST FORER GABBAY & KASIERER
|
|
A Member of Ernst & Young Global
|
|
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 6706703, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
|
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 6706703, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
|
Tel Aviv, Israel
March 26, 2014
|
/s/
Kost Forer Gabbay & Kasierer
KOST FORER GABBAY & KASIERER
|
|
A Member of Ernst & Young Global
|
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$ | 42,813 | $ | 50,026 | ||||
|
Restricted cash and deposits
|
- | 146 | ||||||
|
Short-term bank deposits
|
38,000 | 78,042 | ||||||
|
Available-for-sale marketable securities
|
40,798 | 14,841 | ||||||
|
Trade receivables (net of allowance for doubtful accounts of $ 441 and $ 280 at December 31, 2013 and 2012 respectively)
|
16,908 | 20,236 | ||||||
|
Other receivables and prepaid expenses
|
8,218 | 6,815 | ||||||
|
Inventories
|
13,798 | 9,963 | ||||||
|
Total
current assets
|
160,535 | 180,069 | ||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Severance pay fund
|
254 | 213 | ||||||
|
Deferred taxes
|
1,602 | 1,525 | ||||||
|
Other assets
|
771 | 239 | ||||||
|
Total
non-current assets
|
2,627 | 1,977 | ||||||
|
PROPERTY AND EQUIPMENT, NET
|
5,874 | 6,609 | ||||||
|
INTANGIBLE ASSETS, NET
|
9,407 | 12,322 | ||||||
|
GOODWILL
|
20,814 | 20,814 | ||||||
|
Total
assets
|
$ | 199,257 | $ | 221,791 | ||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$ | 3,191 | $ | 4,809 | ||||
|
Employees and payroll accruals
|
6,129 | 8,182 | ||||||
|
Deferred revenues
|
12,504 | 13,829 | ||||||
|
Liability related to settlement of OCS grants (See note 11a)
|
- | 15,886 | ||||||
|
Other payables and accrued expenses
|
4,777 | 5,765 | ||||||
|
Total
current liabilities
|
26,601 | 48,471 | ||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Deferred revenues
|
2,447 | 3,945 | ||||||
|
Accrued severance pay
|
282 | 254 | ||||||
|
Total
long-term liabilities
|
2,729 | 4,199 | ||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
SHAREHOLDERS' EQUITY:
|
||||||||
|
Share capital -
|
||||||||
|
Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at December 31, 2013 and 2012;
Issued
and outstanding: 32,877,118 and 32,547,151 shares at December 31, 2013 and 2012, respectively
|
774 | 761 | ||||||
|
Additional paid-in capital
|
242,629 | 233,985 | ||||||
|
Accumulated other comprehensive income
|
366 | 1,760 | ||||||
|
Accumulated deficit
|
(73,842 | ) | (67,385 | ) | ||||
|
Total
shareholders' equity
|
169,927 | 169,121 | ||||||
|
Total
liabilities and shareholders' equity
|
$ | 199,257 | $ | 221,791 | ||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
$ | 66,318 | $ | 77,127 | $ | 56,810 | ||||||
|
Services
|
30,227 | 27,625 | 20,943 | |||||||||
|
Total
revenues
|
96,545 | 104,752 | 77,753 | |||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
20,572 | 26,857 | 19,540 | |||||||||
|
Services
|
6,246 | 4,180 | 2,635 | |||||||||
|
Expenses related to settlement of OCS grants (See note 11a)
|
- | 15,886 | - | |||||||||
|
Total
cost of revenues
|
26,818 | 46,923 | 22,175 | |||||||||
|
Gross profit
|
69,727 | 57,829 | 55,578 | |||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development (net of grant participations of $ 1,051, $ 2,855 and
$ 3,674 for the years ended December 31, 2013, 2012 and 2011, respectively
)
|
27,022 | 22,060 | 13,222 | |||||||||
|
Sales and marketing
|
39,817 | 34,127 | 26,543 | |||||||||
|
General and administrative
|
9,952 | 10,664 | 7,474 | |||||||||
|
Total
operating expenses
|
76,791 | 66,851 | 47,239 | |||||||||
|
Operating income (loss)
|
(7,064 | ) | (9,022 | ) | 8,339 | |||||||
|
Financial income, net
|
(727 | ) | (1,358 | ) | (415 | ) | ||||||
|
Income (loss) before income tax expenses (benefit)
|
(6,337 | ) | (7,664 | ) | 8,754 | |||||||
|
Income tax expenses (benefit)
|
120 | (926 | ) | (55 | ) | |||||||
|
Net income (loss)
|
$ | (6,457 | ) | $ | (6,738 | ) | $ | 8,809 | ||||
|
Unrealized gain (loss) on available-for-sale marketable securities
|
(20 | ) | 15 | 68 | ||||||||
|
Unrealized gain (loss) on foreign currency cash flow hedges transactions
|
(1,374 | ) | 2,555 | (1,312 | ) | |||||||
|
Total comprehensive income (loss)
|
$ | (7,851 | ) | $ | (4,168 | ) | $ | 7,565 | ||||
| Net earnings (loss) per share: | ||||||||||||
|
Basic
|
$ | (0.20 | ) | $ | (0.21 | ) | $ | 0.35 | ||||
|
Diluted
|
$ | (0.20 | ) | $ | (0.21 | ) | $ | 0.33 | ||||
| Weighted average number of shares used in per share computations of net earnings (loss): | ||||||||||||
|
Basic
|
32,680,766 | 31,959,921 | 25,047,771 | |||||||||
|
Diluted
|
32,680,766 | 31,959,921 | 27,071,872 | |||||||||
|
Ordinary shares
|
Additional paid-in capital | Accumulated other comprehensive income (loss) | Accumulated deficit | Total shareholders' equity | ||||||||||||||||||||
|
Outstanding shares
|
Amount
|
|||||||||||||||||||||||
|
Balance at January 1, 2011
|
23,806,313 | $ | 527 | $ | 133,483 | $ | 434 | $ | (69,456 | ) | $ | 64,988 | ||||||||||||
|
Issuance of shares related to secondary offering, net of issuance costs (*)
|
6,325,000 | 169 | 84,753 | - | - | 84,922 | ||||||||||||||||||
|
Exercise of stock options
|
818,921 | 24 | 2,814 | - | - | 2,838 | ||||||||||||||||||
|
Stock-based compensation
|
- | - | 2,256 | - | - | 2,256 | ||||||||||||||||||
|
Other comprehensive loss
|
- | - | - | (1,244 | ) | - | (1,244 | ) | ||||||||||||||||
|
Net income
|
- | - | - | - | 8,809 | 8,809 | ||||||||||||||||||
|
Balance at December 31, 2011
|
30,950,234 | $ | 720 | $ | 223,306 | $ | (810 | ) | $ | (60,647 | ) | $ | 162,569 | |||||||||||
|
Exercise of stock options
|
1,596,917 | 41 | 5,862 | - | - | 5,903 | ||||||||||||||||||
|
Stock-based compensation
|
- | - | 4,817 | - | - | 4,817 | ||||||||||||||||||
|
Other comprehensive gain
|
- | - | - | 2,570 | - | 2,570 | ||||||||||||||||||
|
Net loss
|
- | - | - | - | (6,738 | ) | (6,738 | ) | ||||||||||||||||
|
Balance at December 31, 2012
|
32,547,151 | $ | 761 | $ | 233,985 | $ | 1,760 | $ | (67,385 | ) | $ | 169,121 | ||||||||||||
|
Ordinary shares
|
Additional paid-in capital |
Accumulated other
|
Accumulated deficit | Total shareholders' equity | ||||||||||||||||||||
|
Outstanding shares
|
Amount
|
comprehensive income (loss)
|
||||||||||||||||||||||
|
Balance at December 31, 2012
|
32,547,151 | $ | 761 | $ | 233,985 | $ | 1,760 | $ | (67,385 | ) | $ | 169,121 | ||||||||||||
|
Exercise of stock options
|
329,967 | 13 | 913 | - | - | 926 | ||||||||||||||||||
|
Stock-based compensation
|
- | - | 7,731 | - | - | 7,731 | ||||||||||||||||||
|
Other comprehensive loss
|
- | - | - | (1,394 | ) | - | (1,394 | ) | ||||||||||||||||
|
Net loss
|
- | - | - | - | (6,457 | ) | (6,457 | ) | ||||||||||||||||
|
Balance at December 31, 2013
|
32,877,118 | $ | 774 | $ | 242,629 | $ | 366 | $ | (73,842 | ) | $ | 169,927 | ||||||||||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Accumulated unrealized gain on available-for-sale marketable securities
|
$ | 41 | $ | 61 | $ | 45 | ||||||
|
Accumulated unrealized gain (loss) on foreign currency cash flows hedge transactions
|
325 | 1,699 | (855 | ) | ||||||||
|
Accumulated other comprehensive income (loss) (see note 2u)
|
$ | 366 | $ | 1,760 | $ | (810 | ) | |||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income (loss)
|
$ | (6,457 | ) | $ | (6,738 | ) | $ | 8,809 | ||||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||||||
|
Depreciation and amortization
|
6,338 | 5,067 | 2,878 | |||||||||
|
Stock-based compensation
|
7,731 | 4,817 | 2,256 | |||||||||
|
Capital loss
|
18 | 20 | 7 | |||||||||
|
Decrease (increase) in accrued severance pay, net
|
(13 | ) | - | 12 | ||||||||
|
Decrease (increase) in other assets
|
(532 | ) | 6 | 98 | ||||||||
|
Decrease in accrued interest and amortization of premium on marketable securities
|
366 | 212 | 151 | |||||||||
|
Decrease (increase) in trade receivables
|
3,328 | (8,139 | ) | (1,187 | ) | |||||||
|
Decrease (increase) in other receivables and prepaid expenses
|
(2,749 | ) | 1,159 | (970 | ) | |||||||
|
Decrease (increase) in inventories, net
|
(3,835 | ) | 3,233 | 329 | ||||||||
|
Increase in long-term deferred taxes, net
|
(77 | ) | (931 | ) | (227 | ) | ||||||
|
Decrease in trade payables
|
(1,618 | ) | (1,287 | ) | (2,456 | ) | ||||||
|
Increase (decrease) in employees and payroll accruals
|
(2,053 | ) | 2,392 | (748 | ) | |||||||
|
Increase (decrease) in deferred revenues
|
(2,823 | ) | (7,089 | ) | 7,423 | |||||||
|
Increase (decrease) in other payables and accrued expenses
|
(988 | ) | 84 | (1,178 | ) | |||||||
|
Liability related to settlement of OCS grants (See Note 11a)
|
(15,886 | ) | 15,886 | - | ||||||||
|
Net cash provided by (used in) operating activities
|
(19,250 | ) | 8,692 | 15,197 | ||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Decrease (increase) in restricted cash and deposits
|
146 | 913 | (78 | ) | ||||||||
|
Investments in short-term bank deposits
|
- | (54,042 | ) | (24,000 | ) | |||||||
|
Proceeds of short-term bank deposits
|
40,042 | - | - | |||||||||
|
Purchase of property and equipment
|
(2,706 | ) | (3,820 | ) | (2,953 | ) | ||||||
|
Proceeds from sale of property and equipment
|
- | - | 30 | |||||||||
|
Investment in available-for sale marketable securities
|
(32,805 | ) | (8,194 | ) | (4,735 | ) | ||||||
|
Proceeds from sales of available-for-sale marketable securities
|
2,597 | 750 | 803 | |||||||||
|
Proceeds from maturity of available-for-sale marketable securities
|
3,864 | 9,986 | 1,800 | |||||||||
|
Payments (and loan issued) for subsidiaries acquired, net of cash (see schedule A below)
|
- | (24,892 | ) | - | ||||||||
|
Net cash provided by (used in) investing activities
|
11,138 | (79,299 | ) | (29,133 | ) | |||||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Issuance of shares related to secondary offering, net
|
- | - | 84,922 | |||||||||
|
Proceeds from exercise of stock options
|
899 | 5,903 | 2,838 | |||||||||
|
Repayment of bank loan
|
- | (1,952 | ) | - | ||||||||
|
Net cash provided by financing activities
|
899 | 3,951 | 87,760 | |||||||||
|
Increase (decrease) in cash and cash equivalents
|
(7,213 | ) | (66,656 | ) | 73,824 | |||||||
|
Cash and cash equivalents at the beginning of the year
|
50,026 | 116,682 | 42,858 | |||||||||
|
Cash and cash equivalents at the end of the year
|
$ | 42,813 | $ | 50,026 | $ | 116,682 | ||||||
|
Supplementary cash flow information:
|
||||||||||||
|
Cash paid (received) during the year for:
|
||||||||||||
|
Taxes
|
$ | (9 | ) | $ | (48 | ) | $ | 100 | ||||
|
Schedule A- Acquisitions of subsidiaries (see also Note 1b):
|
||||||||||||
|
Estimated net fair value of assets acquired and liabilities assumed at the date of acquisition was as follows:
|
||||||||||||
|
Working capital, net (excluding cash and cash equivalents)
|
$ | - | $ | (4,501 | ) | $ | - | |||||
|
Equipment and other assets
|
- | 597 | - | |||||||||
|
Intangible assets
|
14,025 | |||||||||||
|
Goodwill
|
- | 17,663 | - | |||||||||
|
Deferred tax assets, net
|
- | 409 | - | |||||||||
|
Long-term liabilities
|
- | (1,952 | ) | - | ||||||||
|
Total Consideration
|
$ | - | $ | 26,241 | $ | - | ||||||
|
Non cash - Contingent Consideration (See also note 1b)
|
$ | - | (1,349 | ) | $ | - | ||||||
|
Payments (and loan issued) for subsidiaries acquired, net of cash
|
$ | - | $ | 24,892 | $ | - | ||||||
|
Schedule B –non cash activities during the year for:
|
||||||||||||
|
Proceeds from exercise of stock options
|
$ | 27 | $ | - | $ | - | ||||||
|
NOTE 1:
|
GENERAL
|
|
|
a.
|
Allot Communications Ltd. (the "Company") was incorporated in November 1996 under the laws of the State of Israel. The Company is engaged in developing, selling and marketing intelligent IP service optimization solutions for mobile, DSL and wireless broadband carriers, cable operator service providers, and enterprises. The Company's portfolio of hardware platforms and software applications utilizes advanced deep packet inspection technology to transform broadband pipes into smart networks that can rapidly and efficiently manage data over mobile and wireline networks and deploy value added Internet services. The Company's products consist of the Service Gateway and NetEnforcer traffic management systems, the NetXplorer and Subscribe Management Platform application management suites and value added services such as the Service Protector network protection solution, the MediaSwift video caching solution and the WebSafe network service.
|
|
NOTE 1:
|
GENERAL (CONT.)
|
|
|
b.
|
Acquisitions:
|
|
1.
|
On May 15, 2012 (the "Ortiva acquisition date"), the Company entered into a share purchase agreement (the "Ortiva SPA") with the shareholders of Ortiva Wireless Inc. ("Ortiva") a private, California-based company that develops video optimization solutions for mobile and internet networks. The Company paid $ 10,816 in cash as consideration for all the shares of Ortiva.
The acquisition was accounted for using the purchase method of accounting in accordance with ASC No. 805, “Business Combinations” ("ASC No. 805"). Accordingly, the purchase price was allocated according to the estimated fair values of the assets acquired and liabilities assumed and the excess of the purchase price over the net tangible and identified intangible assets was assigned to goodwill. The fair value of intangible assets was determined by management with the assistance of a third party valuation.
The results of Ortiva's operations have been included in the Company’s consolidated financial statements since the Ortiva acquisition date. Revenues recognized from the Ortiva acquisition date to December 31, 2012 were $ 3,404.
On December 31, 2012 Ortiva was merged into the U.S. subsidiary.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:
|
|
Fair value
|
||||
|
Current assets
|
$ | 1,967 | ||
|
Equipment
|
459 | |||
|
Deferred revenues
|
(1,803 | ) | ||
|
Current and non-current liabilities
|
(3,949 | ) | ||
|
Deferred tax assets, net
|
409 | |||
|
Technology
|
3,899 | |||
|
Backlog
|
910 | |||
|
Goodwill
|
8,924 | |||
|
Net assets acquired
|
$ | 10,816 | ||
|
NOTE 1:
|
GENERAL (CONT.)
|
|
|
2.
|
On September 4, 2012, (the "Oversi acquisition date") the Company entered into a share purchase agreement (the "Oversi SPA") with the shareholders of Oversi Networks Ltd ("Oversi"), a private, Israeli-based company that develops and sells products and systems for caching Internet content.
The total consideration for the acquisition was $ 17,349, which consisted of $ 16,000 in cash and contingent consideration estimated at fair value of $ 1,349 at the Oversi acquisition date.
Pursuant to the Oversi SPA, the Company had a contingent liability to pay additional consideration if Oversi reaches a certain threshold of bookings for the year ended December 31, 2012. As of December 31, 2012, the fair value of the contingent consideration was determined to be $ 1,088 and was presented in other payables and accrued expenses. During 2013, the fair value of the contingent consideration was estimated to $ 0 as the booking threshold was not achieved. The changes in fair value of the contingent consideration were recorded in general and administrative expenses.
The acquisition of Oversi was accounted for using the purchase method of accounting in accordance with ASC No. 805. Accordingly, the purchase price has been allocated according to the estimated fair value of the assets acquired and liabilities assumed. The excess of the purchase price over the net tangible and identified intangible assets was assigned to goodwill. The fair value of the intangible assets and the contingent consideration was determined by management with the assistance of a third party valuation.
The results of Oversi's operations have been included in the Company consolidated financial statements since September 4, 2012. Revenues recognized from the Oversi acquisition date to December 31, 2012 were $ 1,954.
On December 31, 2012, Oversi was merged into the Company.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:
|
|
Fair value
|
||||
|
Current assets
|
$ | 4,182 | ||
|
Equipment and other assets
|
138 | |||
|
Deferred revenues
|
(936 | ) | ||
|
Other current liabilities
|
(2,038 | ) | ||
|
Bank loan
|
(1,952 | ) | ||
|
Technology
|
6,826 | |||
|
Backlog
|
1,491 | |||
|
Customer relationships
|
899 | |||
|
Goodwill
|
8,739 | |||
|
Net assets acquired
|
$ | 17,349 | ||
|
NOTE 1:
|
GENERAL (CONT.)
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
|
a.
|
Use of estimates:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
b.
|
Financial statements in U.S. dollars:
|
|
|
c.
|
Principles of consolidation:
|
|
|
d.
|
Cash and cash equivalents:
|
|
|
e.
|
Restricted cash and deposits:
|
|
|
f.
|
Short-term bank deposits:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
g.
|
Marketable securities:
|
|
|
h.
|
Inventories:
|
|
|
i.
|
Property and equipment:
|
|
%
|
||
|
Lab equipment
|
25 - 33
|
|
|
Computers and peripheral equipment
|
15 - 33
|
|
|
Office furniture
|
6 - 15
|
|
|
Leasehold improvements
|
By the shorter of term of the lease or the useful life of the asset
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
j.
|
Goodwill impairment:
|
|
|
k.
|
Impairment of long lived assets and intangible assets subject to amortization:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
l.
|
Revenue recognition:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
m.
|
Advertising expenses:
|
|
|
n.
|
Research and development costs:
|
|
|
o.
|
Severance pay:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
p.
|
Accounting for stock-based compensation:
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Cost of revenues
|
$ | 368 | $ | 222 | $ | 103 | ||||||
|
Research and development
|
1,666 | 1,186 | 442 | |||||||||
|
Sales and marketing
|
3,106 | 2,060 | 1,001 | |||||||||
|
General and administrative
|
2,591 | 1,349 | 710 | |||||||||
|
Total stock-based compensation expense
|
$ | 7,731 | $ | 4,817 | $ | 2,256 | ||||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Suboptimal exercise multiple
|
3 | 2.5-3.5 | 2.5-3.5 | |||||||||
|
Risk free interest rate
|
0.1%-2.77 | % | 0.15%-1.39 | % | 0.11%-5.46 | % | ||||||
|
Volatility
|
53%-63 | % | 51%-66 | % | 50%-53 | % | ||||||
|
Dividend yield
|
0 | % | 0 | % | 0 | % | ||||||
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
q.
|
Concentration of credit risks:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
r.
|
Grants from the OCS:
|
|
|
s.
|
Income taxes:
|
|
|
t.
|
Basic and diluted net income/loss per share:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
u.
|
Comprehensive income (loss):
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
Year ended December 31, 2013
|
||||||||||||
|
Unrealized gains (losses) on marketable securities
|
Unrealized gains (losses) on cash flow hedges
|
Total
|
||||||||||
|
Balance as of December 31, 2012
|
$ | 61 | $ | 1,699 | $ | 1,760 | ||||||
|
Changes in other comprehensive income (loss) before reclassifications
|
(5 | ) | 1,636 | 1,631 | ||||||||
|
Amounts reclassified from accumulated other comprehensive income to :
|
||||||||||||
|
Cost of revenues
|
- | (184 | ) | (184 | ) | |||||||
|
Operating expenses
|
- | (2,826 | ) | (2,826 | ) | |||||||
|
Financial income, net
|
(15 | ) | - | (15 | ) | |||||||
|
Net current-period other comprehensive loss
|
(20 | ) | (1,374 | ) | (1,394 | ) | ||||||
|
Balance as of December 31, 2013
|
$ | 41 | $ | 325 | $ | 366 | ||||||
|
|
Level 1 -
|
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
Level 2 -
|
Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and
|
|
|
Level 3 -
|
Unobservable inputs which are supported by little or no market activity.
|
|
|
w.
|
Derivatives and hedging:
|
|
|
x.
|
Business combinations:
|
|
NOTE 2:
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
y.
|
Warranty costs:
|
|
NOTE 3:
|
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
|
|
December 31, 2013
|
December 31, 2012
|
|||||||||||||||||||||||||||||||
|
Amortized cost
|
Gross unrealized gain
|
Gross unrealized
loss
|
Fair
value
|
Amortized cost
|
Gross
unrealized
gain
|
Gross unrealized
loss
|
Fair
value
|
|||||||||||||||||||||||||
|
Available-for-sale - matures within one year:
|
||||||||||||||||||||||||||||||||
|
Governmental debentures
|
$ | - | $ | - | $ | - | $ | - | $ | 200 | $ | 1 | $ | - | $ | 201 | ||||||||||||||||
|
Corporate debentures
|
3,921 | 7 | - | 3,928 | 3,701 | 12 | - | 3,713 | ||||||||||||||||||||||||
| 3,921 | 7 | - | 3,928 | 3,901 | 13 | - | 3,914 | |||||||||||||||||||||||||
|
Available-for-sale - matures after one year through three years:
|
||||||||||||||||||||||||||||||||
|
Governmental debentures
|
1,673 | 4 | (1 | ) | 1,676 | 933 | 4 | (4 | ) | 933 | ||||||||||||||||||||||
|
Corporate debentures
|
35,163 | 77 | (46 | ) | 35,194 | 9,946 | 48 | - | 9,994 | |||||||||||||||||||||||
| 36,836 | 81 | (47 | ) | 36,870 | 10,879 | 52 | (4 | ) | 10,927 | |||||||||||||||||||||||
| $ | 40,757 | $ | 88 | $ | (47 | ) | $ | 40,798 | $ | 14,780 | $ | 65 | $ | (4 | ) | $ | 14,841 | |||||||||||||||
|
NOTE 4:
|
FAIR VALUE MEASUREMENTS
|
|
NOTE 4:
|
FAIR VALUE MEASUREMENTS (CONT.)
|
|
As of December 31, 2013
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Available-for-sale marketable securities
|
$ | - | $ | 40,798 | $ | - | $ | 40,798 | ||||||||
|
Foreign currency derivative contracts
|
- | 264 | - | 264 | ||||||||||||
|
Total financial assets
|
$ | - | $ | 41,062 | $ | - | $ | 41,062 | ||||||||
|
As of December 31, 2012
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Available-for-sale marketable securities
|
$ | - | $ | 14,841 | $ | - | $ | 14,841 | ||||||||
|
Foreign currency derivative contracts
|
- | 1,624 | - | 1,624 | ||||||||||||
|
Total financial assets
|
$ | - | $ | 16,465 | $ | - | $ | 16,465 | ||||||||
|
NOTE 5:
|
DERIVATIVE INSTRUMENTS
|
|
NOTE 5:
|
DERIVATIVE INSTRUMENTS (CONT.)
|
|
Foreign exchange forward and
|
December 31,
|
|||||||||
|
options contracts
|
Balance sheet
|
2013
|
2012
|
|||||||
|
Fair value of foreign exchange forward contracts, net
|
Other receivables and prepaid expenses
|
325 | 1,699 | |||||||
|
Total derivatives designated as hedging instrument
|
$ | 325 | $ | 1,699 | ||||||
|
Total derivatives not designated as hedging instruments, net
|
Other payables and accrued expenses
|
$ | (61 | ) | $ | (75 | ) | |||
|
NOTE 5:
|
DERIVATIVE INSTRUMENTS (CONT.)
|
|
NOTE 6:
|
OTHER RECEIVABLES AND PREPAID EXPENSES
|
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Prepaid expenses
|
$ | 5,815 | $ | 2,772 | ||||
|
Government authorities
|
1,540 | 1,284 | ||||||
|
Short-term lease deposits
|
282 | 211 | ||||||
|
Foreign currency derivative contracts
|
325 | 1,702 | ||||||
|
Grants receivable from the OCS
|
94 | 224 | ||||||
|
Others
|
162 | 622 | ||||||
| $ | 8,218 | $ | 6,815 | |||||
|
NOTE 7:
|
INVENTORIES
|
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Raw materials
|
$ | 3,693 | $ | 2,371 | ||||
|
Finished products
|
10,105 | 7,592 | ||||||
| $ | 13,798 | $ | 9,963 | |||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Cost:
|
||||||||
|
Lab equipment
|
$ | 9,967 | $ | 8,134 | ||||
|
Computers and peripheral equipment
|
17,405 | 16,910 | ||||||
|
Office furniture and equipment
|
675 | 606 | ||||||
|
Leasehold improvements
|
674 | 703 | ||||||
| 28,721 | 26,353 | |||||||
|
Accumulated depreciation:
|
||||||||
|
Lab equipment
|
6,676 | 5,093 | ||||||
|
Computers and peripheral equipment
|
15,293 | 13,770 | ||||||
|
Office furniture and equipment
|
398 | 358 | ||||||
|
Leasehold improvements
|
480 | 523 | ||||||
| 22,847 | 19,744 | |||||||
|
Depreciated cost
|
$ | 5,874 | $ | 6,609 | ||||
|
NOTE 9:
|
INTANGIBLE ASSETS, NET
|
|
|
a.
|
The following table shows the Company's intangible assets for the periods presented:
|
|
Weighted average remaining useful life
|
December 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Original Cost:
|
||||||||
|
Technology
|
6.1 | $ | 10,725 | $ | 11,451 | |||
|
Backlog
|
1.0 | 1,491 | 2,401 | |||||
|
Customer relationships
|
2.5 | 899 | 899 | |||||
| $ | 13,115 | $ | 14,751 | |||||
|
Accumulated amortization:
|
||||||||
|
Technology
|
6.1 | $ | 2,103 | $ | 1,217 | |||
|
Backlog
|
1.0 | 1,330 | 1,168 | |||||
|
Customer relationships
|
2.5 | 275 | 44 | |||||
| $ | 3,708 | $ | 2,429 | |||||
|
Amortized cost
|
$ | 9,407 | $ | 12,322 | ||||
|
NOTE 9:
|
INTANGIBLE ASSETS, NET
(CONT.)
|
|
|
b.
|
Amortization expense for the years ended December 31, 2013, 2012 and 2011 was $ 2,915, $ 1,947 and $ 124, respectively.
|
|
|
c.
|
Estimated amortization expense for the years ending:
|
|
Year ending December 31,
|
||||
|
2014
|
$ | 1,912 | ||
|
2015
|
1,718 | |||
|
2016
|
1,621 | |||
|
2017
|
1,489 | |||
|
Thereafter
|
2,667 | |||
|
Total
|
$ | 9,407 | ||
|
NOTE 10:
|
OTHER PAYABLES AND ACCRUED EXPENSES
|
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Accrued expenses
|
$ | 3,806 | $ | 3,887 | ||||
|
Foreign currency derivative contracts
|
61 | 78 | ||||||
|
Contingent consideration payable
|
- | 1,088 | ||||||
|
Accrual taxes
|
824 | 409 | ||||||
|
Others
|
86 | 303 | ||||||
| $ | 4,777 | $ | 5,765 | |||||
|
NOTE 11:
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
|
a.
|
Royalties:
|
|
NOTE 11:
|
COMMITMENTS AND CONTINGENT LIABILITIES (CONT.)
|
|
|
b.
|
Lease commitments:
|
|
Year ending December 31,
|
||||
|
2014
|
$ | 2,908 | ||
|
2015
|
2,156 | |||
|
2016
|
1,836 | |||
|
2017
|
1,736 | |||
|
Thereafter
|
905 | |||
|
Total
|
$ | 9,541 | ||
|
NOTE 11:
|
COMMITMENTS AND CONTINGENT LIABILITIES (CONT.)
|
|
|
c.
|
Major subcontractor:
|
|
|
d.
|
Purchase commitments:
|
|
NOTE 12:
|
SHAREHOLDERS' EQUITY
|
|
|
a.
|
Company's shares:
|
|
|
b.
|
Stock option plan:
|
|
Year ended December 31,
|
||||||||||||||||||||||||
|
2013
|
2012
|
2011
|
||||||||||||||||||||||
|
Number
of shares upon exercise
|
Weighted average exercise price
|
Number
of shares upon exercise
|
Weighted average exercise price
|
Number
of shares upon exercise
|
Weighted average exercise price
|
|||||||||||||||||||
|
Outstanding at beginning of year
|
2,709,910 | $ | 11.03 | 3,164,090 | $ | 5.90 | 3,427,870 | $ | 3.81 | |||||||||||||||
|
Granted
|
764,224 | $ | 11.52 | 1,301,455 | $ | 8.11 | 649,000 | $ | 14.31 | |||||||||||||||
|
Forfeited
|
(254,956 | ) | $ | 11.63 | (158,718 | ) | $ | 12.15 | (93,859 | ) | $ | 8.57 | ||||||||||||
|
Exercised
|
(329,967
|
) | $ | 2.85 | (1,596,917 | ) | $ | 3.72 | (818,921 | ) | $ | 3.46 | ||||||||||||
|
Outstanding at end of year
|
2,889,211 | $ | 11.96 | 2,709,910 | $ | 11.03 | 3,164,090 | $ | 5.90 | |||||||||||||||
|
Exercisable at end of year
|
1,364,620 | $ | 10.38 | 819,869 | $ | 6.62 | 1,592,432 | $ | 3.66 | |||||||||||||||
|
Vested and Expected to Vest
|
2,117,348 | $ | 11.65 | 1,686,435 | $ | 9.86 | 2,324,031 | $ | 4.80 | |||||||||||||||
|
NOTE 12:
|
SHAREHOLDERS' EQUITY (CONT.)
|
|
Exercise price
|
Shares upon exercise of options outstanding as of December 31, 2013
|
Weighted average remaining contractual life
|
Shares upon exercise of options exercisable as of December 31, 2013
|
|||||||||||
|
Years
|
||||||||||||||
| $ | 23.31-27.58 | 456,969 | 8.57 | 153,876 | ||||||||||
| $ | 16.82-17.07 | 317,410 | 7.96 | 148,099 | ||||||||||
| $ | 11.32-15.43 | 1,024,648 | 8.43 | 323,948 | ||||||||||
| $ | 5.25-9.25 | 256,401 | 6.63 | 221,876 | ||||||||||
| $ | 0-4.95 | 833,783 | 8.54 | 516,821 | ||||||||||
| 2,889,211 | 1,364,620 | |||||||||||||
|
NOTE 12:
|
SHAREHOLDERS' EQUITY (CONT.)
|
|
NOTE 13:
|
TAXES ON INCOME
|
|
|
a.
|
Corporate tax rates:
The Israeli corporate tax rate was 24% in 2011 and 25% in 2012 and 2013.
|
|
|
b.
|
Foreign Exchange Regulations:
|
|
NOTE 13:
|
TAXES ON INCOME (CONT.)
|
|
|
c.
|
Tax benefits under Israel's law for the Encouragement of Capital Investments, 1959 ("the Law"):
|
|
NOTE 13:
|
TAXES ON INCOME (CONT.)
|
|
NOTE 13:
|
TAXES ON INCOME (CONT.)
|
|
|
e.
|
Tax benefits under the law for the Encouragement of Industry (Taxes), 1969 (the "Encouragement Law"):
|
|
|
f.
|
Pre-tax income (loss) is comprised as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Domestic
|
$ | (6,556 | ) | $ | (2,372 | ) | $ | 9,737 | ||||
|
Foreign
|
219 | (5,292 | ) | (983 | ) | |||||||
| $ | (6,337 | ) | $ | (7,664 | ) | $ | 8,754 | |||||
|
NOTE 13:
|
TAXES ON INCOME (CONT.)
|
|
|
g.
|
A reconciliation of the theoretical tax expenses (benefit), assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses (benefit) is as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Income (loss) before taxes on income
|
$ | (6,337 | ) | $ | (7,664 | ) | $ | 8,754 | ||||
|
Theoretical tax expense (benefit) computed at the Israeli statutory tax rate (25%, 25% and 24% for the years 2013, 2012 and 2011, respectively)
|
$ | (1,584 | ) | $ | (1,916 | ) | $ | 2,101 | ||||
|
Creation (Utilization) of valuation allowance
|
931 | (1,554 | ) | (4,328 | ) | |||||||
|
Increase (decrease) in losses and temporary differences due to change in Israeli corporate " and Approved Enterprise" tax
|
3,056 | (7,073 | ) | 5,419 | ||||||||
|
Increase (decrease) in valuation allowance related to losses and temporary differences due to change in Israeli corporate " and Approved Enterprise" tax
|
(3,056 | ) | 7,073 | (5,419 | ) | |||||||
|
Taxes with respect to prior years
|
- | 2 | (84 | ) | ||||||||
|
Impairment (recording) of withholding tax asset
|
- | - | 221 | |||||||||
|
Increase in deferred tax assets related to losses and temporary differences due to changes in tax rates and different basis of measurement
|
(594 | ) | ||||||||||
|
Non-deductible expenses and other
|
(223 | ) | 1,699 | (27 | ) | |||||||
|
Non-deductible share-based compensation expenses
|
1,590 | 833 | 541 | |||||||||
|
Exchange rate differences
|
- | 10 | 1,521 | |||||||||
|
Actual tax expenses (benefit)
|
$ | 120 | $ | (926 | ) | $ | (55 | ) | ||||
|
NOTE 13:
|
TAXES ON INCOME (CONT.)
|
|
|
h.
|
Income tax expense (tax benefit) is comprised as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Current taxes (benefit)
|
$ | 408 | $ | (2 | ) | $ | 31 | |||||
|
Deferred taxes benefit
|
(288 | ) | (926 | ) | (223 | ) | ||||||
|
Taxes in respect of previous years
|
- | 2 | (84 | ) | ||||||||
|
Impairment (recording) of withholding tax asset
|
- | - | 221 | |||||||||
| $ | 120 | $ | (926 | ) | $ | (55 | ) | |||||
|
|
i.
|
Net operating losses carry forward:
|
|
NOTE 13:
|
TAXES ON INCOME (CONT.)
|
|
|
j.
|
Deferred income taxes:
|
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Operating and capital loss carryforwards
|
$ | 14,567 | $ | 11,264 | ||||
|
Reserves and allowances
|
785 | 215 | ||||||
|
Deferred tax asset before valuation allowance
|
15,352 | 11,479 | ||||||
|
Valuation allowance
|
(12,736 | ) | (8,749 | ) | ||||
|
Net deferred tax asset
|
2,616 | 2,730 | ||||||
|
Deferred tax liability
|
(609 | ) | (1,006 | ) | ||||
|
Net deferred tax asset
|
$ | 2,007 | $ | 1,724 | ||||
|
|
k.
|
As of December 31, 2013 and 2012, the provision in respect of ASC 740 was immaterial. The Company accrues interest and penalties related to the provision in income taxes in its statement of operations. Such interest and penalties were immaterial for all reported periods.
|
|
NOTE 14:
|
GEOGRAPHIC INFORMATION
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Europe
|
$ | 21,753 | $ | 39,655 | $ | 38,409 | ||||||
|
Asia and Oceania
|
29,909 | 21,953 | 20,195 | |||||||||
|
United States of America
|
21,350 | 24,674 | 9,484 | |||||||||
|
Middle East and Africa
|
18,210 | 10,565 | 2,723 | |||||||||
|
Americas (excluding United States of America)
|
5,323 | 7,905 | 6,942 | |||||||||
| $ | 96,545 | $ | 104,752 | $ | 77,753 | |||||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Customer A
|
17 | % | 14 | % | 15 | % | ||||||
|
Customer B
|
17 | % | - | - | ||||||||
|
Customer C
|
11 | % | - | - | ||||||||
| 45 | % | 14 | % | 15 | % | |||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Long-lived assets:
|
||||||||
|
Israel
|
$ | 27,747 | $ | 26,976 | ||||
|
United States of America
|
10,514 | 14,380 | ||||||
|
Other
|
207 | 153 | ||||||
| $ | 38,468 | $ | 41,509 | |||||
|
NOTE 15:
|
FINANCIAL EXPENSES (INCOME), NET
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Financial income:
|
||||||||||||
|
Interest income
|
$ | (1,358 | ) | $ | (1,746 | ) | $ | (661 | ) | |||
|
Financial expenses:
|
||||||||||||
|
Exchange rate differences and other
|
47 | 176 | 95 | |||||||||
|
Amortization/accretion of premium/discount on marketable securities , net
|
584 | 212 | 151 | |||||||||
| $ | (727 | ) | $ | (1,358 | ) | $ | (415 | ) | ||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Numerator:
|
||||||||||||
|
Net income (loss)
|
$ | (6,457 | ) | $ | (6,738 | ) | $ | 8,809 | ||||
|
Denominator:
|
||||||||||||
|
Weighted average number of shares outstanding used in computing basic net earnings per share
|
32,680,766 | 31,959,921 | 25,047,771 | |||||||||
|
Dilutive effect: stock options
|
- | - | 2,024,101 | |||||||||
|
Total weighted average number of shares used in computing diluted net earnings per share
|
32,680,766 | 31,959,921 | 27,071,872 | |||||||||
|
Basic net earnings (loss) per share
|
$ | (0.20 | ) | $ | (0.21 | ) | $ | 0.35 | ||||
|
Diluted net earnings (loss) per share
|
$ | (0.20 | ) | $ | (0.21 | ) | $ | 0.33 | ||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|